Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;5(2):129-138.
doi: 10.15212/FMCH.2017.0127.

Complex multimorbidity and health outcomes in older adult cancer survivors

Affiliations

Complex multimorbidity and health outcomes in older adult cancer survivors

David F Warner et al. Fam Med Community Health. 2017 Jul.

Abstract

Objective: To characterize complex multimorbidity among cancer survivors and evaluate the association between cancer survivorship, time since cancer diagnosis, and self-reported fair/poor health, self-rated worse health in 2 years, and 2-year mortality.

Methods: We used the 2010-2012 Health and Retirement Study. Cancer survivors were individuals who reported a (nonskin) cancer diagnosis 2 years or more before the interview. We defined complex multimorbidity as the co-occurrence of chronic conditions, functional limitations, and/or geriatric syndromes. In addition to descriptive analyses, we used logistic regression to evaluate the independent association between cancer survivor status and health outcomes. We also examined whether cancer survivorship differed by the number of years since diagnosis.

Results: Among 15,808 older adults (age ≥50 years), 11.8% were cancer survivors. Compared with cancer-free individuals, a greater percentage of cancer survivors had complex multimorbidity: co-occurring chronic conditions, functional limitations, and geriatric syndromes. Cancer survivorship was significantly associated with self-reported fair/poor health, self-rated worse health in 2 years, and 2-year mortality. These effects declined with the number of years since diagnosis for fair/ poor health and mortality but not for self-rated worse health.

Conclusion: Cancer survivor status is independently associated with more complex multimorbidity, and with worse health outcomes. These effects attenuate with time, except for patient perception of being in worse health.

Keywords: Comorbidity; cancer survivorship; functional limitations; geriatric syndromes; health decline; health status; mortality; multimorbidity.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Results from the multivariable analysis showing the association between cancer survivor status and health outcomes, after adjustment for sociodemographic characteristics and multimorbidity.
Fig. 2.
Fig. 2.
Results from the multivariable analysis showing the association between time elapsed since cancer diagnosis and health outcomes, after adjustment for sociodemographic characteristics and multimorbidity.

References

    1. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland J, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 2016;66(4):271–89. - PubMed
    1. Sharp L, Deady S, Gallagher P, Molcho M, Pearce A, Thomas AA, et al. The magnitude and characteristics of the population of cancer survivors: using population-based estimates of cancer prevalence to inform service planning for survivorship care. BMC Cancer 2014;14:767. - PMC - PubMed
    1. Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev 2016;25(7):1029–36. - PMC - PubMed
    1. Leach CR, Weaver KE, Aziz NM, Alfano CM, Bellizzi KM, Kent E, et al. The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J Cancer Surviv 2015;9(2):239–51. - PubMed
    1. Kalam K, Marwick TH. Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis. Eur J Cancer 2013;49(13):2900–9. - PubMed

LinkOut - more resources